started · updated
Flu vaccine availability and uptake issues reported in Brazil and Portugal
Flu vaccination campaigns are facing distinct challenges in Brazil and Portugal. In Brazil, low vaccination rates have been reported in Espírito Santo and several other regions, with coverage in some areas falling between 41% and 60%, well below the 90% target for priority groups. This low uptake, combined with climate fluctuations linked to El Niño, has extended the circulation of respiratory viruses. In Brazil, influenza has been linked to over 17,000 severe cases and 1,300 deaths in 2026, increasing the risk of complications such as pneumonia and myocardial infarction in the elderly.
In Portugal, the National Association of Pharmacies (ANF) confirmed a shortage of flu vaccines intended for the private sector. These vaccines, which are purchased directly by pharmacies for individuals not included in the priority groups defined by the Directorate-General of Health, are currently unavailable. The ANF noted that the supply of these doses dropped from approximately 300,000 in 2025 to 50,000 this year. The shortage is attributed to international circumstances, including new WHO requirements for vaccine strains and pharmaceutical production issues, which have led manufacturers to prioritize national health campaigns.
Entities
Brazil · Directorate-General of Health · National Association of Pharmacies · Portugal · World Health Organization